Prognostic and predictive tumor-based biomarkers in patients (pts) with advanced renal cell carcinoma (RCC) treated with interferon alpha (IFN) with or without bevacizumab (Bev): Results from CALGB (Alliance) 90206
- Citation:
- J Clin Oncol vol 32 (5s) (suppl; abstr 4532)
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Harriet M. Kluger Susan Halabi Nicole C Solomon Lucia Jilaveanu Christopher Zito Joshua Sznol Andrew B. Nixon Brian I. Rini Eric Jay Small Daniel J. George
- Networks:
- Study
- CALGB-90206
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: